Cookies help us deliver our services. By using our services, you agree to our use of cookies.
Learn more
OK
Skip to main content (Press Enter).
Sign In
Skip auxiliary navigation (Press Enter).
Contact Us
Skip main navigation (Press Enter).
Toggle navigation
Search Options
About
What is the AMS
AMS International Scientific Committee
AMS North America Scientific Committee
AMS Educational Executive Committee
AMS Ambassadors
Certifications and Educational Credits
Upcoming Events
Videos & Webinars
International Events
Become a Speaker
Videos On Demand
Education 365
Preview AMS TV
Features
AMS Features
News & Publications
AMS Bookstore
Blogs
Industry
Industry Partners
Become a Sponsor
Features
Blogs
Blog Viewer
Blogs
Liraglutide improved inflammation via mediating IL-23/Th-17 pathway in obese diabetic mice with psoriasiform skin
By
- AMS
posted
Jan 04, 2020 03:00 AM
0
Recommend
Volume 32, Issue 7
, November 2021, Page 745-751
.
0 comments
0 views
Permalink
Related Content
The therapeutic effects of blocking IGF-R1 on mice model of skin cancer
- AMS
Added Jan 04, 2020
Blog Entry
Anti-TNF agent etanercept augments UV-induced skin cancer development in SKH-1 mice
- AMS
Added Jan 07, 2020
Blog Entry
MiR-486-5p inhibits the hyperproliferation and production of collagen in hypertrophic scar fibroblasts via IGF1/PI3K/AKT pathway
- AMS
Added Feb 21, 2020
Blog Entry
Secukinumab rapidly improves EQ-5D health status in patients with psoriasis: Pooled analysis from four phase 3 trials
- AMS
Added Jan 04, 2020
Blog Entry
Topical administration of mangiferin promotes healing of the wound of streptozotocin-nicotinamide-induced type-2 diabetic male rats
- AMS
Added Feb 04, 2020
Blog Entry
© 2022 AMS, Aesthetic Multispecialty Society. All Rights Reserved.
Powered by Higher Logic